Journal article
Antibody therapy for rheumatoid arthritis.
- Abstract:
-
High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to protect joints from structural damage. Other targets for therapeutic antibodies include the cytokines interleukin (IL)-1, IL-6, IL-8, IL-15, IL-17 and IL-18. In addition, there is preliminary evidence...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Current opinion in pharmacology
- Volume:
- 3
- Issue:
- 3
- Pages:
- 323-328
- Publication date:
- 2003-06-01
- DOI:
- EISSN:
-
1471-4973
- ISSN:
-
1471-4892
- Source identifiers:
-
227095
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:227095
- UUID:
-
uuid:5285acb2-db50-4730-924c-56ebbc331d7d
- Local pid:
- pubs:227095
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2003
If you are the owner of this record, you can report an update to it here: Report update to this record